This is an old revision of this page, as edited by Vortexjourney754 (talk | contribs) at 23:01, 16 December 2024 (delete category). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 23:01, 16 December 2024 by Vortexjourney754 (talk | contribs) (delete category)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)| Company type | Private |
|---|---|
| Industry | Venture capital |
| Founded | February 2021; 3 years ago (2021-02) |
| Founder | Maximillian Naza |
| Headquarters | San Francisco, California, U.S. |
| Products | Investments |
| Website | https://bias.capital/ |
Bias Capital, LLC (commonly known as Bias Capital) is an American venture capital firm that invests in both early-stage start-ups and established growth companies. In addition to its primary investments, the firm operates an angel syndicate, offering accredited investors and qualified purchasers the opportunity to access and participate in select investment opportunities.
Bias Capital operates as the venture capital arm of PasciVite.
Notable Investments
In July 2023, Bias Capital led a $25 million Series A funding round for Parker Health, a biotech company focused on revolutionizing electronic health records and healthcare management.
Other notable investments include Grabango, Wayflyer, Fintor, Valtivis, Flower CO. and FLYR.
References
- "Bias Capital". web.archive.org. 2021-10-06. Retrieved 2024-12-16.
- "Parker Health Secures $25 Million in Series A Funding to Transform American Healthcare". Archived from the original on 2024-10-05. Retrieved 2024-12-13.
- "Bias Capital Investment Portfolio | PitchBook". pitchbook.com. Retrieved 2024-12-16.